TJ Biopharma
PrivateLast Round
Series C
Extension
Sep 30, 2025
Total Funding Raised
$116M
Company Overview
TJ Biopharma is a biotechnology company that develops, manufactures, and commercializes innovative biologics for autoimmune diseases, immuno-oncology, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TJ Biopharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
TJ Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 30, 2025 | ||||
| Series C Extension | Feb 7, 2024 | ||||
| Series B | Jul 16, 2022 | ||||
| Series A | Sep 15, 2020 |
TJ Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series C Extension |
| CCIC Capital | Series C Extension |
| Hangzhou Industrial & Commercial Trust | Series A, Series B |
| Viva Biotech | Series A, Series B |
| Value Partners Group | Series A, Series B |
| Yijing Capital | Series C Extension |
| Zhejiang Haibang Private Equity Fund Management Co., Ltd. | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2022
$46M round with participation from Value Partners Group.
TJ Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TJ Biopharma's valuation, stock price, and market status.